Abstract
Catechol-O-methyl transferase (COMT) is an enzyme involved in estrogen metabolism. Proteomic and immunoproteomic screens suggested COMT might be an immunogenic membrane antigen in human pancreatic cancer. The aim of this study was to investigate the dynamic expression of COMT in pancreatic ductal adenocarcinoma (PDAC) and noncancerous pancreatic tissue, and to determine the relationship between COMT expression and clinicopathologic parameters. COMT expression was analyzed by reverse transcription-polymerase chain reaction (RT-PCR) and western blot in five pancreatic cell lines and five pairs of PDAC and noncancerous pancreatic tissue. Immunohistochemistry was used to evaluate COMT expression in tissue microarrays and 20 cases of paraffin-embedded clinical specimens. The results indicated that COMT expression was detected in AsPC-1, BxPC-3, MIA PaCa-2, Capan-1 and SW1990 pancreatic cell lines, and in five pairs of PDAC and noncancerous pancreatic tissue, at the mRNA and protein levels. Immunohistochemistry analysis revealed that COMT expression was significantly higher in PDAC than in nonmalignant pancreatic tissue. High expression of COMT significantly correlated to early T stages. Therefore, we conclude that COMT might serve as a potential biomarker for applied clinical pathology in PDAC.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 2011, 61: 212–236
Hidalgo M. Pancreatic cancer. N Engl J Med, 2010, 362: 1605–1617
Gillen S, Schuster T, Meyer Zum Buschenfelde C, et al. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med, 2010, 7: e1000267
Kim B J, Lee K T, Moon T G, et al. How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects? Dig Liver Dis, 2009, 41: 364–369
Duffy M J, Sturgeon C, Lamerz R, et al. Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann Oncol, 2010, 21: 441–447
Pan B, Zhao Y P, Ning L, et al. Proteomic analysis of membrane proteins of endomembrane system in human pancreatic cancer cell (in Chinese). Zhonghua Wai Ke Za Zhi, 2010, 48: 461–465
Wang W B, Zhao Y P, Liao Q, et al. Candidate immunogenic membrane antigens of human pancreatic cancer (in Chinese). Zhonghua Wai Ke Za Zhi, 2010, 48: 1412–1415
Dempster E L, Mill J, Craig I W, et al. The quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression. BMC Med Genet, 2006, 7: 10
Wu W M, Zhao Y P, Liao Q, et al. The expression of catechol O-methyltransferase gene in colorectal cancer (in Chinese). Zhonghua Wai Ke Za Zhi, 2010, 48: 535–538
Thompson P A, Shields P G, Freudenheim J L, et al. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res, 1998, 58: 2107–2110
Ahsan H, Chen Y, Whittemore A S, et al. A family-based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk. Breast Cancer Res Treat, 2004, 85: 121–131
Ji Y, Olson J, Zhang J, et al. Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms. Cancer Res, 2008, 68: 5997–6005
Hirata H, Hinoda Y, Okayama N, et al. COMT polymorphisms affecting protein expression are risk factors for endometrial cancer. Mol Carcinog, 2008, 47: 768–774
Freedman N D, Ahn J, Hou L, et al. Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer. Carcinogenesis, 2009, 30: 71–77
Kahlert C, Bergmann F, Beck J, et al. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer. BMC Cancer, 2011, 11: 275
Huber J C, Schneeberger C, Tempfer C B. Genetic modeling of estrogen metabolism as a risk factor of hormone-dependent disorders. Maturitas, 2002, 41: S55–64
Cavalieri E L, Stack D E, Devanesan P D, et al. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA, 1997, 94: 10937–10942
Yager J D, Liehr J G. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol, 1996, 36: 203–232
Pribluda V S, Gubish E R Jr., Lavallee T M, et al. 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metastasis Rev, 2000, 19: 173–179
Qanungo S, Basu A, Das M, et al. 2-Methoxyestradiol induces mitochondria dependent apoptotic signaling in pancreatic cancer cells. Oncogene, 2002, 21: 4149–4157
Kreiger N, Lacroix J, Sloan M. Hormonal factors and pancreatic cancer in women. Ann Epidemiol, 2001, 11: 563–567
Duell E J, Holly E A. Reproductive and menstrual risk factors for pancreatic cancer: a population-based study of San Francisco Bay Area women. Am J Epidemiol, 2005, 161: 741–747
Karhunen T, Tilgmann C, Ulmanen I, et al. Distribution of catechol-O-methyltransferase enzyme in rat tissues. J Histochem Cytochem, 1994, 42: 1079–1090
Theve N O, Pousette A, Carlstrom K. Adenocarcinoma of the pancreas—a hormone sensitive tumor? A preliminary report on Nolvadex treatment. Clin Oncol, 1983, 9: 193–197
Tonnesen K, Kamp-Jensen M. Antiestrogen therapy in pancreatic carcinoma: a preliminary report. Eur J Surg Oncol, 1986, 12: 69–70
Keating J J, Johnson P J, Cochrane A M, et al. A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma. Br J Cancer, 1989, 60: 789–792
Iwao K, Miyoshi Y, Ooka M, et al. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in human pancreatic cancers by real-time polymerase chain reaction. Cancer Lett, 2001, 170: 91–97
Konduri S, Schwarz R E. Estrogen receptor beta/alpha ratio predicts response of pancreatic cancer cells to estrogens and phytoestrogens. J Surg Res, 2007, 140: 55–66
Author information
Authors and Affiliations
Corresponding author
Additional information
Contributed equally to this work
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Wu, W., Zhang, J., Zhou, L. et al. Increased COMT expression in pancreatic cancer and correlation with clinicopathologic parameters. Sci. China Life Sci. 55, 747–752 (2012). https://doi.org/10.1007/s11427-012-4375-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-012-4375-y